Cargando…
Salivary metabolite signatures of oral cancer and leukoplakia through gas chromatography-mass spectrometry
BACKGROUND: Saliva contains a large array of metabolites, many of which can be informative for the detection of diseases. Gas chromatography-mass spectrometry (GC-MS) is a system that has long been used for metabolite profiling owing to its sensitivity, specificity, reproducibility and synchronized...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106257/ https://www.ncbi.nlm.nih.gov/pubmed/35571322 http://dx.doi.org/10.4103/jomfp.jomfp_335_21 |
_version_ | 1784708241679187968 |
---|---|
author | Tantray, Shoborose Sharma, Seema Prabhat, Kanika Nasrullah, Nazima Gupta, Manu |
author_facet | Tantray, Shoborose Sharma, Seema Prabhat, Kanika Nasrullah, Nazima Gupta, Manu |
author_sort | Tantray, Shoborose |
collection | PubMed |
description | BACKGROUND: Saliva contains a large array of metabolites, many of which can be informative for the detection of diseases. Gas chromatography-mass spectrometry (GC-MS) is a system that has long been used for metabolite profiling owing to its sensitivity, specificity, reproducibility and synchronized analysis; it has relatively broad coverage of compound classes including sugars, sugar alcohols, glycosides and lipophilic compounds. AIM AND OBJECTIVES: The present study was conducted to explore the use of GC-MS in assessing variation in salivary metabolites and to recognize the metabolites which can be used as disease diagnostic tools and metabolite markers for detection of oral squamous cell carcinoma. MATERIALS AND METHODS: The present study included clinically and histopathologically confirmed oral squamous cell carcinoma (OSCC) and oral leukoplakia patients (OLK) and the control group. Patients were divided into three groups: OSCC (n = 30), OLK (n = 30) and healthy individuals as controls (n = 30). Patients were refrained from eating, drinking, smoking or oral hygiene procedures for at least 1.5 h before the collection. Saliva was collected between 9.00 and 10.00 am. Samples were stored at −80°C. Filtered samples were used for GC-MS. RESULTS: Fifteen compounds differed significantly between control, OLK and OSCC. These metabolites were decanedioic acid, 2-methyloctacosane, eicosane, octane, 3,5-dimethyl, pentadecane, hentriacontane, 5, 5-diethylpentadecane, nonadecane, oxalic acid, 6-phenylundecanea, l-proline, 2-furancarboxamide, 2-isopropyl-5-methyl-1-heptanol, pentanoic acid, Docosane. CONCLUSION: The findings of the study suggest the application of salivary metabolomics as a promising tool in the identification of tumor-specific biomarkers in early diagnosis and prediction of OSCC and oral leukoplakia. In future, standardizing the protocol for salivary analysis and overcoming some of the limitations will be helpful to establish salivary metabolomics as a reliable, the highly sensitive and specific method for clinical use as an independent diagnostic aid. |
format | Online Article Text |
id | pubmed-9106257 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-91062572022-05-14 Salivary metabolite signatures of oral cancer and leukoplakia through gas chromatography-mass spectrometry Tantray, Shoborose Sharma, Seema Prabhat, Kanika Nasrullah, Nazima Gupta, Manu J Oral Maxillofac Pathol Original Article BACKGROUND: Saliva contains a large array of metabolites, many of which can be informative for the detection of diseases. Gas chromatography-mass spectrometry (GC-MS) is a system that has long been used for metabolite profiling owing to its sensitivity, specificity, reproducibility and synchronized analysis; it has relatively broad coverage of compound classes including sugars, sugar alcohols, glycosides and lipophilic compounds. AIM AND OBJECTIVES: The present study was conducted to explore the use of GC-MS in assessing variation in salivary metabolites and to recognize the metabolites which can be used as disease diagnostic tools and metabolite markers for detection of oral squamous cell carcinoma. MATERIALS AND METHODS: The present study included clinically and histopathologically confirmed oral squamous cell carcinoma (OSCC) and oral leukoplakia patients (OLK) and the control group. Patients were divided into three groups: OSCC (n = 30), OLK (n = 30) and healthy individuals as controls (n = 30). Patients were refrained from eating, drinking, smoking or oral hygiene procedures for at least 1.5 h before the collection. Saliva was collected between 9.00 and 10.00 am. Samples were stored at −80°C. Filtered samples were used for GC-MS. RESULTS: Fifteen compounds differed significantly between control, OLK and OSCC. These metabolites were decanedioic acid, 2-methyloctacosane, eicosane, octane, 3,5-dimethyl, pentadecane, hentriacontane, 5, 5-diethylpentadecane, nonadecane, oxalic acid, 6-phenylundecanea, l-proline, 2-furancarboxamide, 2-isopropyl-5-methyl-1-heptanol, pentanoic acid, Docosane. CONCLUSION: The findings of the study suggest the application of salivary metabolomics as a promising tool in the identification of tumor-specific biomarkers in early diagnosis and prediction of OSCC and oral leukoplakia. In future, standardizing the protocol for salivary analysis and overcoming some of the limitations will be helpful to establish salivary metabolomics as a reliable, the highly sensitive and specific method for clinical use as an independent diagnostic aid. Wolters Kluwer - Medknow 2022 2022-03-31 /pmc/articles/PMC9106257/ /pubmed/35571322 http://dx.doi.org/10.4103/jomfp.jomfp_335_21 Text en Copyright: © 2022 Journal of Oral and Maxillofacial Pathology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Tantray, Shoborose Sharma, Seema Prabhat, Kanika Nasrullah, Nazima Gupta, Manu Salivary metabolite signatures of oral cancer and leukoplakia through gas chromatography-mass spectrometry |
title | Salivary metabolite signatures of oral cancer and leukoplakia through gas chromatography-mass spectrometry |
title_full | Salivary metabolite signatures of oral cancer and leukoplakia through gas chromatography-mass spectrometry |
title_fullStr | Salivary metabolite signatures of oral cancer and leukoplakia through gas chromatography-mass spectrometry |
title_full_unstemmed | Salivary metabolite signatures of oral cancer and leukoplakia through gas chromatography-mass spectrometry |
title_short | Salivary metabolite signatures of oral cancer and leukoplakia through gas chromatography-mass spectrometry |
title_sort | salivary metabolite signatures of oral cancer and leukoplakia through gas chromatography-mass spectrometry |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106257/ https://www.ncbi.nlm.nih.gov/pubmed/35571322 http://dx.doi.org/10.4103/jomfp.jomfp_335_21 |
work_keys_str_mv | AT tantrayshoborose salivarymetabolitesignaturesoforalcancerandleukoplakiathroughgaschromatographymassspectrometry AT sharmaseema salivarymetabolitesignaturesoforalcancerandleukoplakiathroughgaschromatographymassspectrometry AT prabhatkanika salivarymetabolitesignaturesoforalcancerandleukoplakiathroughgaschromatographymassspectrometry AT nasrullahnazima salivarymetabolitesignaturesoforalcancerandleukoplakiathroughgaschromatographymassspectrometry AT guptamanu salivarymetabolitesignaturesoforalcancerandleukoplakiathroughgaschromatographymassspectrometry |